Remsima ™ – the first biosimilar infliximab
Drug profileGastroent Hepatol 2014; 68(2): 178-179.
pdf Tibor HlavatýCitrafleet ® – simple and effective bowel preparation before the procedure
Drug profileGastroent Hepatol 2014; 68(3): 274-275.
pdf Milan LukášNew development in the treatment of acute and chronic diarrhea in the Czech Republic – Tammex family and Tammex family plus
Drug profileGastroent Hepatol 2014; 68(4): 367-369.
pdf Jan MartínekPrevenar 13 – a vaccine of choice in prophylaxis of pneumococcal infections in immunocompromised patients
Drug profileGastroent Hepatol 2014; 68(4): 373-375.
pdf Martin BortlíkBudenofalk 2 mg rectal foam represents a major new option in the treatment of patients with ulcerous colitis
Drug profileGastroent Hepatol 2012; 66(5): 413-414.
pdf Milan LukášMutaflor – Escherichia coli kmen Nissle 1917, sérotyp O6:K5:H1
Drug profileGastroent Hepatol 2013; 67(2): 170-171.
pdf Milan Lukáš